Search results
Sputnik V (Russian: Спутник V, the brand name from the Russian Direct Investment Fund or RDIF) or Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced [4]) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and ...
Sputnik V (ros. Спутник V), oficjalnie: Gam-COVID-Vac (ros. Гам-КОВИД-Вак) – pierwsza szczepionka przeciw COVID-19 na świecie opracowana przez Centrum Epidemiologii i Mikrobiologii im. Nikołaja Gamelei. Została zarejestrowana 11 sierpnia 2020 przez Ministerstwo Ochrony Zdrowia Federacji Rosyjskiej.
Sputnik V to szczepionka opracowana przez rosyjskie Narodowe Centrum Epidemiologii i Mikrobiologii im. Gamalei. Szczepionka ta stosowana jest już m.in. w Rosji, obecnie EMA rozpoczęła ocenę tej szczepionki.
20 lut 2021 · Denis Logunov and colleagues 1 report their interim results from a phase 3 trial of the Sputnik V COVID-19 vaccine in The Lancet. The trial results show a consistent strong protective effect across all participant age groups.
15 kwi 2021 · President Vladimir Putin has touted Sputnik V as "the best vaccine in the world," and the Russian media have regularly touted the vaccine's record exports abroad. However, is it actually a...
20 lut 2021 · We report on the interim clinical efficacy results of the rAd26 and rAd5 vector-based COVID-19 vaccine Gam-COVID-Vac in a randomised, double-blind placebo-controlled multicentre phase 3 trial in Moscow, Russia, including 21 862 participants.
2 lut 2021 · Russia's Sputnik V coronavirus vaccine gives around 92% protection against Covid-19, late stage trial results published in The Lancet reveal. It has also been deemed to be safe - and offer...
